NEW DELHI, NOV 7 : Alembic Pharma on Tuesday reported 2.40% year-on-year increase in consolidated net profit at Rs 136.56 crore for July-September quarter (Q2) of the current financial year 2023-24.

The company had posted a profit of Rs 133.35 crore in Q2 of 2022-23.

Alembic Pharma’s revenue from operations in Q2FY24 stood at Rs 1,594.93 crore as against Rs 1,475.01 crore in Q2FY23 registering 8.13% year-on-year growth.

“Despite the challenges of a muted demand in the Antibiotic and respiratory market, it was a satisfactory quarter, backed with a strong performance by our specialty and animal healthcare portfolio. We are confident of returning to an industry beating growth moving forward,” said Shaunak Amin, Managing Director, Alembic Pharma.

Shares of Alembic Pharma closed 1.23% higher at Rs 739.95 a piece on the BSE on Tuesday.(UNI)